Metabolic syndrome in Saudi Arabia

Saudi Medical Journal

Volumn 26, Issue 12, 2005, Pages 1918-1925

  Al Nozha, Mansour M ^a,h   Al Khadra, Akram ^f   Arafah, Mohammed R ^a   Al Maatouq, Mohammed A ^a   Khalil, Mohamed Z ^a   Khan, Nazeer B ^b   Al Mazrou, Yaqoub Y ^c   Al Marzouki, Khalid ^g   Al Harthi, Saad S ^a   Abdullah, Moheeb ^d   Al Shahid, Maie S ^e   Al Mobeireek, Abdulellah ^a   Nouh, Mohmmed S ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c MINISTRY OF HEALTH   (Saudi Arabia)

^d PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^e KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^f IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^g KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^h TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION DISTRIBUTION; PREVALENCE; RISK FACTOR; SAUDI ARABIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROBABILITY; RISK FACTORS; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 31844436917     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Bjorntorp P. Abdominal obesity and the metabolic syndrome (Review). Ann Med 1994; 24: 465-468.
3. Groop L, Ekstrand A, Forsblom C, Wide'n E, Groop PH, Teppo AM, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 642-647.
4. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DJ, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes 1998; 47: 793-800.
5. Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 1999; 22 (Suppl 3): C25-C30.
6. Hanefeld M, Leonhardt W. Das Metabolische Syndrom. Dt Gesundh Wesen 1981; 36: 545-551.
7. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
8. Descovich GC, Benassi B, Cancelli V, D'Addato S, De Simone, Dormi A. An epidemic view of the plurimetabolic syndrome. In: Crepaleli G, Tiengo A, Manzato E, editors. Diabetes, Obesity and Hyperlipidemias. The Plurimetabolic Syndrome. Amsterdam, Netherlands: Elsevier Science; 1993. p. 31-39.
9. Bouchard C, Perusse L. Genetics of causes and manifestations of the metabolic syndrome. In Diabetes, obesity and hyperlipidemia. In: Crepaldi G, Tiengo A, Manzato E, editors. The plurimetabolic syndrome. Amsterdam: Elsevier Science; 1993. p. 67-74.
10. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520.
11. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 807-817.
12. Haffner S, Valdez R, Hazuda H, Mitchell B, Morales P, Stern M. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
13. Balkau B, Charles MA. Comments on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-443.
14. Alberti KGMM, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
16. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the Metabolic syndrome. Diabetes Care 2001; 24: 683-689.
17. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, et al. 4S Group and the AFCAPS/TexCAPS Research Group: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS); Am J Cardiol 2004; 93: 136-141.
18. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
19. Klein, BE, Klein, R, Lee, KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25: 1790.
20. Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003; 26: 1251.
21. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004; 109: 706.
22. Solymoss BC, Bourassa MG, Lesperance J, Levesque S, Marcil M, Varga S, et al. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Coron Artery Dis 2003; 14: 207-212.
23. Al-Nozha MM, Arafah MR, Al-Mazrou YY, Al-Maatouq MA, Khan NB, Khalil MZ, et al. Coronary artery disease in Saudi Arabia. Saudi Med J 2004; 25: 1165-1171.
24. Linton MF, Fazio S; National Cholesterol Education Program (NCEP)- the third Adult Treatment Panel (ATP III). A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol 2003; 92: 19i-26i.
25. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): Final report. US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute. NIH Publication No. 02-5215. September 2002. Circulation 2002; 106: 3143.
26. Scott CL. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol 2003; 92: 35i-42i.
27. Tracy RP. Inflammation, the metabolic syndrome and cardiovascular risk. Int J Clin Pract Suppl 2003; 134: 10-17.
28. Ginsberg HN. Treatment for patients with the metabolic syndrome. Am J Cardiol 2003; 91: 29E-39E.
29. Ford, ES, Giles, WH, Dietz, WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356.
30. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the Metabolic Syndrome Among Omani Adults. Diabetes Care 2003; 26: 1781-1785.
31. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 2001; 24: 275-279.
32. Enkhmaa B, Shiwaku K, Anuurad E, Nogi A, Kitajima K, Yamasaki M, et al. Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chim Acta 2005; 352: 105-113.
33. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among arab americans. Diabetes Care 2004; 27: 234-238.
34. Athyros VG, Mikhailidis DP, Papageorgiou AA, Didangelos TP, Ganotakis ES, Symeonidis AN, et al. Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study. Curr Med Res Opin 2004; 20: 1691-1701.
35. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults - a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60: 199-204.
36. Ford ES, Giles WH, Mokdad AH. Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults. Diabetes Care 2004; 27: 2444-2449.
37. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513.
38. Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 1999; 50: 517.
39. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670.
40. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158.
41. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167.
42. Grundy SM, Abate N, Chandalia M. Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med 2002; 113 (Suppl 9B): 25S-29S.
43. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004; 25: 1603-1610.
44. St-Onge MP, Janssen I, Heymsfield SB. Metabolic Syndrome in Normal-Weight Americans: New Definition of the Metabolically Obese, Normal-Weight Individual. Diabetes Care 2004; 27: 2222-2228.
45. Ruderman NB, Schneider SH, Berchtold P. The "metabolically obese," normal weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
46. Ruderman NB, Berchtold P, Schneider SH. Obesity associated disorders in normal weight individuals: some speculations. Int J Obes 1982; 6: 151-157.
47. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999; 48: 2210-2214.
48. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.